Ethylenediamine-induced exfoliative erythroderma.
D000628:Aminophylline / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy; D003873:Dermatitis, Exfoliative / Q000139:chemically induced*; D005029:Ethylenediamines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged
D005029:Ethylenediamines; D000628:Aminophylline